CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort Study
暂无分享,去创建一个
M. Prins | A. Bura | P. Prandoni | M. Moia | P. Wells | P. Mannucci | P. Simioni | A. Girolami | M. Huisman | D. Tormene | P. Friederich | B. Sanson
[1] L. Qiu,et al. [Hyperhomocysteinemia and deep-vein thrombosis]. , 2003, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.
[2] M. Prins,et al. Incidence of Venous Thromboembolism in Families with Inherited Thrombophilia , 1999, Thrombosis and Haemostasis.
[3] P. Simioni,et al. Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant , 1998, British journal of haematology.
[4] K. Hamulyák,et al. Laboratory Diagnosis of Hereditary Thrombophilia , 1998, Seminars in thrombosis and hemostasis.
[5] M. Prins,et al. The Incidence of Venous Thromboembolism in Family Members of Patients with Factor V Leiden Mutation and Venous Thrombosis , 1998, Annals of Internal Medicine.
[6] O. Linder,et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. , 1997, The New England journal of medicine.
[7] M. Prins,et al. Frequency of Pregnancy-Related Venous Thromboembolism in Anticoagulant Factor-Deficient Women: Implications for Prophylaxis , 1996, Annals of Internal Medicine.
[8] P. Prandoni,et al. Hyperhomocysteinemia and deep-vein thrombosis. A case-control study. , 1996, Thrombosis and haemostasis.
[9] P. Mannucci,et al. Inherited Thrombophilia*: Part 2 , 1996, Thrombosis and Haemostasis.
[10] P. Reitsma,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.
[11] P. Mannucci,et al. Inherited Thrombophilia: Part 1 , 1996, Thrombosis and Haemostasis.
[12] M. Prins,et al. Familial Thrombophilia: A Review Analysis , 1996 .
[13] Vittorio Pengo,et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) , 1996, The Lancet.
[14] P. Simioni,et al. “Pseudo Homozygous” Activated Protein C Resistance due to Double Heterozygous Factor V Defects (Factor V Leiden Mutation and Type I Quantitative Factor V Defect) Associated with Thrombosis: Report of Two Cases Belonging to Two Unrelated Kindreds , 1996, Thrombosis and Haemostasis.
[15] A. Cogo,et al. Prevalence of Antiphospholipid Antibodies and Lupus Anticoagulant in Juvenile Patients with Objectively Documented Deep-vein Thrombosis , 1996 .
[16] Pieter H. Reitsma,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.
[17] S. Eichinger,et al. The Risk of Thromboembolism in Asymptomatic Patients with Protein C and Protein S Deficiency: A Prospective Cohort Study , 1994, Thrombosis and Haemostasis.
[18] A. Cohen,et al. Clinical findings associated with acute proximal deep vein thrombosis: a basis for quantifying clinical judgment. , 1990, The American journal of medicine.
[19] D. Rosenthal. Recurrent venous thromboembolism in patients with a partial deficiency of protein S: Comp PC, Esmon CT. N Engl J Med 1984;311:1525–1528 , 1985 .
[20] C. Esmon,et al. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. , 1984, The New England journal of medicine.
[21] R. Bertina,et al. Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families. , 1983, The New England journal of medicine.
[22] O. Egeberg. Inherited Antithrombin Deficiency Causing Thrombophilia , 1965, Thrombosis and Haemostasis.